[{"NetIncomeLoss_1_Q2_USD":-14000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"DepreciationAndAmortization_2_Q2_USD":266000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":68073000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":73685000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":2667000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":6096000.0,"InterestPaidNet_2_Q2_USD":325000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":4200000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":71527000.0,"LongTermDebtCurrent_0_Q2_USD":4812000.0,"OtherNoncashIncomeExpense_2_Q2_USD":86000.0,"RestructuringCharges_2_Q2_USD":0.0,"RestructuringCharges_1_Q2_USD":0.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":8264000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":3797000.0,"ProceedsFromCollaborators_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":45000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":59700000.0,"OtherAssetsMiscellaneous_0_Q2_USD":187000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":2500000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1002000.0,"Liabilities_0_Q2_USD":19549000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":70110000.0,"ValueAddedTaxReceivable_0_Q2_EUR":3900000.0,"ShortTermInvestments_0_Q2_USD":0.0,"MinorityInterest_0_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":0.0,"ProceedsFromStockPlans_2_Q2_USD":4000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-3774000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-3774000.0,"CommonStockValue_0_Q2_USD":74000.0,"DepositsAssetsNoncurrent_0_Q2_USD":194000.0,"OtherSundryLiabilities_0_Q2_USD":374000.0,"InvestmentIncomeNet_2_Q2_USD":162000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1941000.0,"InvestmentIncomeNet_1_Q2_USD":43000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-6000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":9463000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":6199000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":56475000.0,"CostsAndExpenses_2_Q2_USD":21927000.0,"CostsAndExpenses_1_Q2_USD":9996000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":70100000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-26186000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-14000000.0,"OtherAssetsNoncurrent_0_Q2_USD":3916000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-83000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-14000000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":73716760.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2301742000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":38966000.0,"CommonStockSharesOutstanding_0_Q2_shares":73716760.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20009000.0,"OtherCostAndExpenseOperating_2_Q2_USD":4200000.0,"OtherCostAndExpenseOperating_1_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":13745000.0,"ValueAddedTaxReceivableNoncurrent_0_Q2_USD":0.0,"AccountsPayableCurrent_0_Q2_USD":658000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q2_USD":130000.0,"NonoperatingIncomeExpense_2_Q2_USD":-4259000.0,"InterestExpense_2_Q2_USD":304000.0,"InterestExpense_1_Q2_USD":137000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":70110000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1417000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":30000.0,"LongTermDebtNoncurrent_0_Q2_USD":2049000.0,"AdditionalPaidInCapital_0_Q2_USD":2358531000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":56863000.0,"IncreaseDecreaseInOperatingLiabilities_2_Q2_USD":-5766000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":969000.0,"NetIncomeLoss_2_Q2_USD":-26186000.0,"NonoperatingIncomeExpense_1_Q2_USD":-4004000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":0.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":260000.0,"StockholdersEquity_0_Q2_USD":56863000.0,"Assets_0_Q2_USD":76412000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":0.0,"StockholdersEquityOther_1_Q2_USD":-31000.0,"ShareBasedCompensation_2_Q2_USD":2169000.0,"ShareBasedCompensation_1_Q2_USD":1000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":59108000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"StockholdersEquityPeriodIncreaseDecrease_1_Q2_USD":3809000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1620000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":2500000.0,"CommonStockSharesAuthorized_0_Q2_shares":166500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-21927000.0,"OperatingIncomeLoss_1_Q2_USD":-9996000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":76412000.0,"PreferredStockSharesAuthorized_0_Q2_shares":33333.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.38,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.19,"ProfitLoss_2_Q2_USD":-26186000.0,"ProfitLoss_1_Q2_USD":-14000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":3755000.0,"OtherLiabilitiesCurrent_0_Q2_USD":2179000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-26186000.0,"Ticker":"CTIC","CIK":"891293","name":"CTI BIOPHARMA CORP","OfficialName":"CTI BioPharma Corp. (DE) Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"472610380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]